News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
698,858 Results
Type
Article (42256)
Company Profile (265)
Press Release (656337)
Section
Business (205360)
Career Advice (2052)
Deals (35577)
Drug Delivery (93)
Drug Development (82163)
Employer Resources (169)
FDA (16233)
Job Trends (14984)
News (347643)
Policy (32732)
Tag
Academia (2622)
Alliances (49867)
Alzheimer's disease (1328)
Approvals (16196)
Artificial intelligence (195)
Bankruptcy (356)
Best Places to Work (11745)
Biotechnology (190)
Breast cancer (219)
Cancer (1647)
Cardiovascular disease (124)
Career advice (1710)
Cell therapy (330)
Clinical research (65930)
Collaboration (637)
Compensation (334)
COVID-19 (2617)
C-suite (147)
Data (1532)
Diabetes (203)
Diagnostics (6281)
Earnings (85364)
Employer resources (146)
Events (111487)
Executive appointments (540)
FDA (17076)
Funding (575)
Gene therapy (232)
GLP-1 (672)
Government (4397)
Healthcare (18911)
Infectious disease (2722)
Inflammatory bowel disease (116)
Interviews (319)
IPO (16478)
Job creations (3681)
Job search strategy (1455)
Layoffs (440)
Legal (7943)
Lung cancer (245)
Manufacturing (231)
Medical device (13317)
Medtech (13322)
Mergers & acquisitions (19426)
Metabolic disorders (542)
Neuroscience (1738)
NextGen: Class of 2025 (6589)
Non-profit (4546)
Northern California (1961)
Obesity (309)
Opinion (203)
Parkinson's disease (122)
Patents (140)
People (57167)
Phase I (20589)
Phase II (29075)
Phase III (21577)
Pipeline (662)
Postmarket research (2604)
Preclinical (8769)
Radiopharmaceuticals (250)
Rare diseases (313)
Real estate (5943)
Regulatory (22014)
Research institute (2380)
Resumes & cover letters (355)
Southern California (1703)
Startups (3656)
United States (17694)
Vaccines (623)
Weight loss (214)
Date
Today (138)
Last 7 days (617)
Last 30 days (2801)
Last 365 days (35011)
2025 (3211)
2024 (35575)
2023 (40463)
2022 (51512)
2021 (56105)
2020 (54477)
2019 (46939)
2018 (35376)
2017 (32518)
2016 (31946)
2015 (38003)
2014 (31699)
2013 (26745)
2012 (28963)
2011 (29617)
2010 (27693)
Location
Africa (741)
Arizona (210)
Asia (38069)
Australia (6268)
California (4512)
Canada (1637)
China (374)
Colorado (206)
Connecticut (215)
Europe (82312)
Florida (656)
Georgia (158)
Illinois (452)
Indiana (254)
Maryland (710)
Massachusetts (3502)
Michigan (192)
Minnesota (329)
New Jersey (1280)
New York (1298)
North Carolina (811)
Northern California (1961)
Ohio (164)
Pennsylvania (1056)
South America (1117)
Southern California (1703)
Texas (664)
Utah (137)
Washington State (449)
698,858 Results for "promis neurosciences inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
ProMIS Neurosciences Issues Letter to Shareholders
January 14, 2025
·
9 min read
Press Releases
ProMIS Neurosciences to Participate in Guggenheim Securities SMID Cap Biotech Conference
January 29, 2025
·
1 min read
Business
ProMIS Neurosciences Announces First Quarter 2024 Financial Results and Recent Highlights
ProMIS Neurosciences Inc. announced financial results for the first quarter ended March 31, 2024 and provided a corporate update.
May 14, 2024
·
10 min read
Press Releases
ProMIS Neurosciences Initiates Phase 1b Clinical Trial (PRECISE-AD) in Alzheimer’s Disease
January 10, 2025
·
8 min read
Press Releases
ProMIS Neurosciences to Participate in 7th Annual Evercore HealthCONx Conference
November 26, 2024
·
1 min read
ProMIS Neurosciences Strengthens Global Intellectual Property Portfolio
ProMIS Neurosciences, Inc. announced that the European Patent Office, Japanese Patent Office and IP Australia, the Australian patent office, have recently allowed composition of matter and method of use patent applications related to ProMIS Neurosciences’ lead product candidate, PMN310, for the treatment of Alzheimer’s disease .
March 11, 2024
·
5 min read
Genetown
ProMIS Neurosciences to Present at the 2024 BIO CEO & Investor Conference
ProMIS Neurosciences Inc. today announced that Neil Warma, Chief Executive Officer of ProMIS Neurosciences, will present at the 2024 BIO CEO & Investor Conference, taking place in-person in New York, NY on February 26-27, 2024.
February 22, 2024
·
1 min read
Press Releases
ProMIS Neurosciences Announces Third Quarter 2024 Financial Results and Recent Highlights
November 14, 2024
·
13 min read
ProMIS Neurosciences to Present in Upcoming Investor Conferences in April 2024
ProMIS Neurosciences Inc., a biotechnology company focused on the generation and development of therapeutics targeting toxic misfolded proteins in neurodegenerative diseases, announced that company management will participate in three upcoming investor conferences.
April 4, 2024
·
1 min read
Business
ProMIS Neurosciences, Inc. Announces Leadership Transition
ProMIS Neurosciences Inc., a biotechnology company focused on the generation and development of antibody therapeutics targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer’s disease, amyotrophic lateral sclerosis and multiple system atrophy, announced a strategic leadership change.
January 3, 2024
·
6 min read
1 of 69,886
Next
